Immucell Corp (ICCC): Revenue
$27.64M
Year ended 2025-12-31
$30.68M
Trailing 12 months to 2026-06-30
+14.2%
3-year compound annual growth
+12.5%
5-year compound annual growth
| Period ended | Revenue | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $27.64M | +4.3% | 2026-03-30, From 2025-01-01 |
| 2024-12-31 | $26.49M | +51.6% | 2026-03-30, From 2024-01-01 |
| 2023-12-31 | $17.47M | -5.9% | 2024-04-01, From 2023-01-01 |
| 2022-12-31 | $18.57M | -3.5% | 2024-04-01, From 2022-01-01 |
| 2021-12-31 | $19.24M | +25.4% | 2023-03-29, From 2021-01-01 |
| 2020-12-31 | $15.34M | +11.8% | 2022-03-30, From 2020-01-01 |
| 2019-12-31 | $13.72M | +24.9% | 2021-03-30, From 2019-01-01 |
| 2018-12-31 | $10.99M | +5.3% | 2020-03-27, From 2018-01-01 |
| 2017-12-31 | $10.43M | n/a | 2019-03-22, From 2017-01-01 |
Revenue at similar companies
| Company | Year ended | Revenue | Change YoY |
|---|---|---|---|
| Immucell Corp (ICCC) | 2025-12-31 | $27.64M | +4.3% |
| Alpha Teknova, Inc. (TKNO) | 2025-12-31 | $40.52M | +7.4% |
| Intellia Therapeutics, Inc. (NTLA) | 2025-12-31 | $67.67M | +16.9% |
| Aspira Women's Health Inc. (AWHL) | 2025-12-31 | $9.22M | +0.4% |
| Anbio Biotechnology (NNNN) | 2025-12-31 | $8.65M | +5.6% |
| Biomerica Inc (BMRA) | 2026-05-31 | $4.45M | -16.2% |
| Insight Molecular Diagnostics Inc. (IMDX) | 2025-12-31 | $4.05M | +115.6% |
| Volitionrx Ltd (VNRX) | 2025-12-31 | $1.73M | +40.0% |
| Celldex Therapeutics, Inc. (CLDX) | 2025-12-31 | $1.54M | -78.0% |
Compare ICCC, TKNO, NTLA, AWHL side by side · Screen every company in In Vitro & In Vivo Diagnostic Substances ↗